How Early Should Basal Insulin Be Used in T2D Management?

Slides:

Advertisements

Similar presentations

Insulin therapy.

Advertisements

New Insulin Formulations

Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.

What's New in Basal Insulin for Diabetes

Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the.

Short-, Intermediate-, Long-Acting Insulins

Diabetic Dyslipidemia in Practice

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Applying Data to Practice

Lifestyle and Professional CGM

Special Consideration in Insulin Therapy

Faster-Acting Insulins

Using the AGP to Standardize Glucose Reporting

New Patient-Friendly Options for Managing Insulin Dosing

The Next Generation of Basal Insulins

Progression After Cancer Immunotherapy in Advanced NSCLC

Modern Strategies for Basal Insulin Use in T2D

Patient Case Discussions in T2D: What Intensification Plan Is Best?

Insulin Innovation.

Updates on Outcomes for Novel T2D Therapies

Updates Abound.

Antihyperglycemic therapy in type 2 diabetes: general recommendations.

SGLT2 Inhibitors in the Modern Era: Why and Where?

Working as a Team for Improved Patient Outcomes in Type 2 Diabetes

Examining CV Effects of Basal Insulin Therapy

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

Chronic Idiopathic Urticaria

Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?

Tailoring Hemophilia Prophylaxis Therapy

Emerging Basal Insulins for Diabetes

GLP-1 Receptor Agonists: How Early Is Appropriate?

Improving Management of Type 2 Diabetes in Hispanic/Latino Patients

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

Integrated Diabetes Care: How Can We Make the Best Use of New Technology?

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Mild to Moderate Asthma

Novel Basal Insulin Formulations in the Modern Era of T2D Management

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Insulin Use in Primary Care: Practice Challenges

Insulin Innovation.

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.

The Importance of Getting the Dose Right in HF

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Predictive Low Glucose Suspend (PLGS)

The Primary Care Guide to New CGM Devices and the AGP

Antihyperglycemic therapy in type 2 diabetes: general recommendations.

The Mitral Valve Patient Learning Objectives

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

Combining Efforts for Older Drivers: Licensing Agencies, Occupational Therapists, and Clinicians.

T2DM Management.

Better Diabetes Control With Novel Basal Insulins

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.

Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.

Insulin Innovation.

Hypoglycemia: The Most Common Barrier to Effective Diabetes Management

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

Insulin in Diabetes Management: Effective Patient Selection Is Key

COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?

Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial

Improving Effective Basal Insulin Use in Clinical Practice

Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.

Selecting Treatment Approaches in Hemophilia

Are All Novel Insulins Proven to Be Equally Safe?

Getting PPG Under Control

Practical Strategies for Overcoming Emotional Barriers to Insulin Initiation in the Primary Care Setting.

Ask the Psoriasis Expert

Emerging Basal Insulins for Diabetes

Fresh perspectives ON BASAL Insulins in diabetes care

The Challenge of Insulin Titration

Presentation transcript:

How Early Should Basal Insulin Be Used in T2D Management?

Insulin: General Recommendations for Patients With Diabetes

Basal Insulin Options

Case Study: 48-Year-Old Woman With Uncontrolled T2D

Clinical Guidelines on the Initiation of Basal Insulin in People With T2D

Barriers/Myths to Insulin Initiation

Overcoming Barriers With Education: Collaborative Model of Care

Nurses

Tips and Tricks on How to Diffuse Anxiety of Starting Insulin

Case Study (cont): 48-Year-Old Woman With Uncontrolled T2D

U300 Glargine Has a Flatter, More Prolonged Time Action Profile and Less Confirmed Hypoglycemia Than U100 Glargine

Half-Life of Insulin Degludec Is Twice as Long as That of Insulin Glargine and Less Nocturnal Hypoglycemia

Insulin Initiation and Titration

Concluding Remarks

Abbreviations